<DOC>
	<DOCNO>NCT01928628</DOCNO>
	<brief_summary>This study aim compare assess efficacy safety combination agent Lercanidipine Valsartan monotherapy Lercanidipine alone patient essential hypertension</brief_summary>
	<brief_title>Phase III Clinical Study Evaluate Efficacy Safety Combination Lercanidipine/Valsartan Hypertensive Patients</brief_title>
	<detailed_description />
	<mesh_term>Lercanidipine</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Patients age ≥ 20 ≤75 year old Patient essential hypertension When BP level measure screen sitDBP &gt; 120 mmHg sitSBP &gt; 180 mmHg Patient difference repeatedly measure blood pressure select arm screening sitSBP≥ 20mmHg sitDBP ≥ 10mmHg</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>